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ABSTRACT
Objective: To review and synthesise qualitative
research studies that have explored patients’ experience
of deep brain stimulation (DBS) in advanced
Parkinson’s disease (PD).
Design: Systematic review and meta-synthesis of
7 original papers, using metaethnography.
Setting: Studies conducted in Denmark, France and
Sweden.
Participants: 116 patients who had undergone DBS
and 9 spouses of patients.
Results: Prior to surgery, the experience of advancing
PD is one of considerable loss and a feeling of loss of
control. There are significant hopes for what DBS can
bring. Following surgery, a sense of euphoria is
described by many, although this does not persist and
there is a need for significant transitions following this.
We suggest that normality as a concept is core to the
experience of DBS and that a sense of control may be
a key condition for normality. Experience of DBS for
patients and spouses, and of the transitions that they
must undertake, is influenced by their hopes of what
surgery will enable them to achieve, or regain
(ie, a new normality).
Conclusions: There is a need for further qualitative
research to understand the nature of these transitions
to inform how best patients and their spouses can be
supported by healthcare professionals before, during
and after DBS. In assessing the outcomes of DBS and
other treatments in advanced PD, we should consider
how to capture holistic concepts such as normality and
control. Studies that examine the outcomes of DBS
require longer term follow-up.
INTRODUCTION
Deep brain stimulation (DBS) is widely used
to treat a range of Parkinson’s disease (PD)
symptoms, typically in advanced PD,
although its efﬁcacy has been tested in
earlier stages.1 DBS is effective in improving
many motor and some non-motor symptoms.
Meta-analysis2 of six randomised controlled
trials (RCTs) of DBS demonstrates signiﬁcant
improvements in motor disability, activities of
daily living, medication use, mental health,
mood, behavioural problems and quality of
life (QoL). However, measures of communi-
cation, dementia and executive functioning
favoured medication controls.
Despite the overall effectiveness of DBS,
observational studies and subgroup analyses
of trial data demonstrate that not all patients
report improvements in QoL. Daniels et al3
found that 43% of patients showed no
improvement at 6 months, and Soulas et al4
found that 37% showed no improvement or
a decline in QoL. For composite indices and
individual domains of global disease speciﬁc
(eg, Parkinson’s Disease Questionnaire
(PDQ)-39), and generic QoL measures,
there are aggregate improvements in motor
signs, mobility, activities of daily living, stigma
and bodily discomfort, but no improvement
or decline in social support, emotional well-
being, cognition and communication.4–7
Studies that have quantiﬁed patients’ and
spouses’ perceived outcome at 3 months
postsurgery show positive ratings in only 47%
and 33% of patients and spouses, respect-
ively.8 9 Other studies have examined the
Strengths and limitations of this study
▪ This is the first review and synthesis of qualita-
tive research examining patients’ experience of
deep brain stimulation for Parkinson’s disease.
▪ The synthesis identifies core overarching con-
cepts that facilitate our understanding of the
experience of deep brain stimulation.
▪ Two papers were of low quality based on meth-
odological reporting but were conceptually rich.
▪ To date, only seven qualitative studies focusing
on the experience of deep brain stimulation have
been undertaken.
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clinical, demographic and psychosocial factors that
might inﬂuence outcomes such as QoL post-DBS.
Factors that have been associated with these outcomes
include age, depression/emotional distress, apathy, levo-
dopa response, time spent in off periods, time since
disease onset and a history of impulse control disorders
or compulsive medication use, although ﬁndings remain
inconclusive.3 4 7 9 10
Most research informing debates about the efﬁcacy
and use of DBS is quantitative, using measurement and
ratings scales. Although Maier et al9 and Lewis et al8 used
qualitative data collection methods (interviews) with
patients and spouses, their accounts were quantiﬁed to
categorise participants into positive or negative outcome
assessments. The only commonly cited exception to this
is the study by Agid et al11 which used semistructured
psychological interviews to explore contrasts in perspec-
tives on improvement post-DBS between clinicians,
patients and spouses.
Qualitative research provides in-depth description,
understanding and explanation of patients’ experi-
ence of disease and treatment. The value of qualitative
evidence as an adjunct to RCTs is well recognised,
with examples of qualitative research being used to
contextualise and understand trial observations.12
Paralleling meta-analysis for quantitative studies, quali-
tative synthesis techniques have been developed to
analyse the ﬁndings of primary qualitative research, to
identify commonality and difference in ﬁndings, and
to arrive at higher order interpretations and explan-
ation of the subjective experience of disease and treat-
ment from a patient perspective.13 We sought to
synthesise existing qualitative research that has exam-
ined patients’ experiences and perspectives related to
DBS. In doing so, we wished to examine whether this
research might provide some further insight into the
variable and often negative assessment of QoL given
by patients and spouses soon after DBS, despite the
apparent overall effectiveness of the procedure as
measured in RCTs.
METHODS
Literature searches
Several strategies were employed to maximise the identi-
ﬁcation of relevant literature.14 15 These included
searching electronic databases (MEDLINE, MEDLINE
In Process and EMBASE via Ovid); CINAHL via EBSCO;
Social Sciences Citation Index and Conference
Proceedings Citation Index (CPCI) via Web of Science
and CENTRAL Trials Register; the Database of Abstracts
of Reviews of Effects; and Health Technology
Assessment Database all via Cochrane Wiley).
Conference abstracts were searched via CPCI (see
above) and British Library’s ZETOC and authors of con-
ference abstracts contacted. Reference lists of included
papers were also searched.
Selection criteria
English language papers published in peer-reviewed
journals, which reported using qualitative methodology
to explore patients’ or spouses’ experiences of DBS for
the treatment of advanced PD, were included. We
included research (one paper) reporting spouses’ per-
spectives as it can help to illuminate the experiences of
patients. The searches (see online supplementary
appendix 1 for an example) applied no date limits (ie,
went back to inception for each database and were run
to the end of February 2015). Searches were part of a
wider project and covered the broader topic of patients’
and spouses’ experience of living with PD. A focus on
DBS was required for this subproject, and relevant
papers were highlighted during the wider screening
process. Papers had to report results of qualitative ana-
lysis based on qualitative data collection methods (eg,
interviews, focus groups, observations). We included
multiple papers from the same data set as long as they
reported the interpretation of different research ques-
tions. Editorials, narrative reviews and papers which
reported the experience of living with advanced PD but
not speciﬁcally in relation to DBS were excluded.
Screening
Following the removal of duplicates, the titles and
abstracts of identiﬁed articles were screened, with exclu-
sion of those not meeting the above selection criteria.
Full-text versions of the remaining articles were reviewed
by two authors ( JM and LLJ) and the list of papers to
be included in the synthesis ﬁnalised via consensus dis-
cussion (ﬁgure 1).
Quality assessment
There remains signiﬁcant discussion in the literature
around quality appraisal of studies included in qualita-
tive syntheses. In particular, there are debates about the
meaning of quality and validity, how to incorporate the
ﬁndings of studies considered to be of lower quality, and
the uncritical use of quality checklists.16 17 We assessed
both the methodological reporting and robustness of
each study using the Critical Appraisal Skills Programme
(CASP) Qualitative Checklist,18 and also their concep-
tual richness. Following this process, it was decided that
all of the identiﬁed studies would be adopted in the
current synthesis. Two studies11 19 which we rated as low
quality in terms of reporting (eg, due to a lack of speci-
ﬁed detail regarding recruitment of participants and
analytical approach) were rated highly in terms of their
conceptual richness.20
Data extraction
Key characteristics of studies (table 1) were extracted
independently by two authors ( JM and LLJ), quality
checked and discrepancies resolved via discussion, ready
for comparative analysis. For each included study, the
following were extracted: authors, title, journal, year of
publication, setting, stated aims and focus, participant
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characteristics, data collection method/s, data collection
time point in relation to DBS, method of analysis,
themes and subthemes presented, and study author
interpretations of data presented. Participant quotations
were also extracted.
Analysis
Metaethnography20 was used to identify, translate and
interpret shared concepts across the papers. The aim
of this approach is interpretive rather than aggrega-
tive, and thus is concordant with the paradigm that
underpins the majority of primary qualitative research
that syntheses are based on.21 Metaethnography is the
longest established tool for synthesising qualitative
research,13 22 and has been used with smaller bodies
of literature and, despite its label and origins, with
non-ethnographic studies.23 We broadly followed the
seven-step process proposed by Noblit and Hare20 and
also used in a worked healthcare example by Britten
et al:21 (1) getting started; (2) deciding what is rele-
vant to the initial interest; (3) reading the studies; (4)
determining how the studies are related; (5) translat-
ing the studies into one another; (6) synthesising
translations and (7) expressing the synthesis. Each
paper, in the form of the extracted document (ﬁrst
and second order constructs), was annotated in detail
by JM and LLJ and then core concepts and the inter-
pretation of these discussed at length to develop the
line of argument presented in this paper. Core con-
cepts were mapped across the papers to ensure that
convergent and divergent cases were considered.
However, it became clear that the studies were broadly
concordant and suitable for the reciprocal translation
that underpins the line of argument developed. The
paper by Haahr et al24 was used as an index paper to
help facilitate the translation of studies into each
other as it was judged to be both conceptually rich
and well reported.20
Figure 1 Flow diagram of included and excluded studies. DARE, Database of Abstracts of Reviews of Effects; DBS, deep brain
stimulation; HTA, Health Technology Assessment; PD, Parkinson’s disease; SSCI, Social Sciences Citation Index.
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Table 1 Key characteristics of included papers
First
author
Year
published Country Study focus/aim* Participants
Data collection
method
Data collection
time point Analysis method
Haahr
et al26
2011 Denmark To explore patients’ life world
and way of managing life with
advanced PD prior to DBS
and what they expect from life
following this treatment
11 participants; 8 men, 3
women; mean age at
time of DBS 60 years
(range 47–67); mean age
at disease onset
46 years (range 30–55);
mean disease duration
15 years (range 7–29)
Audio recorded in-depth
interviews
Pre-DBS:
∼2 weeks prior to
surgery
Guided by the
hermeneutic
phenomenological
methodology of van
Manen
Agid et al11 2006 France To understand the personal,
familial and social difficulties
experienced by patients with
PD following neurosurgery
29 patients; mean age
52.4 years; mean
disease duration
10.8 years
Audio recorded
repeated in-depth open
interviews
Pre-DBS and
post-DBS at two
time points: prior
to and 24 months
after surgery
Not reported
Haahr
et al27
2013 Denmark To explore the lived
experience of being a spouse
to a person living with
advanced PD, before and
during the first year of DBS
9 spouses of patients
with PD; 3 men, 6
women; mean age of the
spouses at their partners’
disease onset 46 years
(range 27–61); mean age
of the spouses at the
time of their partners’
treatment with DBS
61 years (range 41–76)
Audio recorded
longitudinal qualitative
in-depth interviews
Pre-DBS and
post-DBS at 4
time points: 2–4
weeks prior to
surgery, 6 weeks,
6 months and
12 months after
surgery
Thematic analysis
influenced by the
hermeneutic
phenomenological
methodology of van
Manen
Gisquet19 2008 France To understand the personal,
familial and professional
difficulties experienced by
patients in France who have a
neurodegenerative disease
and undergo cerebral
implants
30 participants; 17 men,
13 women; age range
39–79 years
Audio recorded
cross-sectional
interviews
Pre-DBS and
post-DBS at 3
time points: prior
to surgery, 1 day
to 6 months and
at least 2 years
after surgery
Thematic analysis
Haahr
et al24
2010 Denmark To explore and describe the
lived experience of patients
living with advanced PD
during the first year of
treatment with DBS
9 participants†; 6 men
and 3 women; mean age
at DBS 61 years (range
47–67);
mean disease duration
15 years (range 7–29)
Audio recorded
longitudinal qualitative
in-depth interviews
Post-DBS at 3
time points: 6–
8 weeks, 6 and
12 months after
surgery
Guided by the
hermeneutic
phenomenological
methodology of van
Manen
Ahlberg
et al 25
2011 Sweden To explore perspectives of
the way patients speech and
communication changed as a
result of subthalamic nucleus
DBS treatment for PD
4 participants; 2 men,
2 women; aged 61–
79 years; years since
onset 10–32 years
Video recorded
cross-sectional
semistructured
interviews in the
participant’s home
Post-DBS at 1
time point: at
least 2 years after
surgery (range 2–
10 years)
Qualitative content
analysis
Continued
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RESULTS
Summary of included papers
Seven papers11 19 24–28 describing ﬁve studies are included
(table 1). Six explore patients’ (n=116)11 19 24–26 28 and
one spouses’ experiences (n=9).27 Three24 26 27 report
novel aspects from one data set. Studies reported partici-
pants’ experiences pre-DBS,26 pre-DBS and
post-DBS,11 19 27 or post-DBS24 25 28 using cross-
sectional25 26 28 or longitudinal interview data.11 19 24 27
Three collected data in Denmark,24 26 27 two in
France11 19 and two in Sweden.25 28
THE EXPERIENCE OF DBS AND PD
Only one paper26 provides an explicit focus on life prior
to late stage PD and consideration of DBS. We will not
describe these data or other qualitative research focus-
ing on the experience of living with PD outside the
context of DBS in detail as it has been summarised
previously.29
We provide a brief descriptive overview of the chron-
ology of experience of DBS, before a detailed descrip-
tion of the core cross-cutting themes (normality, loss, loss
of control, transitions, hopes) in our interpretation of this
chronology (table 2). These themes are highlighted in
bold in the text.
THE CHRONOLOGY
Pre-DBS
There is a need for higher dosage and more frequent
medication with advancing PD and life is increasingly
focused on the disease and treatment.27 Although
patients are able to maintain some control via medica-
tion, this time of gradual disease progression is described
as a period of considerable loss (ﬁgure 2 ).11 19 24–27
Eventually, advanced PD is characterised by unpredict-
ability and a feeling of loss of control19 24–28 as the effect-
iveness of medication diminishes. Studies that present
data on pre-DBS perspectives indicate that surgery is
viewed as a ‘last resort’11 19 25 26 and that the choice to
undergo DBS is not much of a choice at all:
I was ready for an operation when the rigidity and the
dyskinesia superseded each other, so that I did not get
any good time in between. (Patient25)
There appear to be signiﬁcant hopes19 24–28 for what
the surgery can bring, hopes that are inﬂuenced by this
experience of loss and loss of control.
Post-DBS
Immediately postsurgery, a sense of euphoria11 19 25 27 28
is reported by many patients, resulting from the new
found (or regained) sense of freedom initially afforded
by the procedure. Haahr et al24 indicate that this persists
for some, but collectively the evidence describes a need
for signiﬁcant transitions to a new disease state and life,
following this initial euphoria. Although Haahr et al24
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suggest that patients and spouses can ﬁnd a clear reso-
lution with their new disease state and life post-DBS, it is
unclear whether all, or what proportion of patients
manage successful transitions. However, those papers that
report an overall assessment indicate that, although not
uncomplicated, over time, the overall impacts of the
surgery are judged positively by patients.28
CORE THEMES AND THEIR INTER-RELATIONSHIP
Our interpretation is that normality as a concept is a core
component of the experience of DBS and the meaning
of that for patients. In turn, control may be a key condi-
tion for a sense of normality, with loss of control precluding
that. Experience of DBS and the transitions post-DBS
link to hopes that the surgery will allow people to
achieve, or regain, normality in life. In turn, this should
be understood within the context of the seemingly irrev-
ocable loss and loss of control that patients, spouses and
those around them experience during late stage PD.
Normality
Normality11 19 24 25 27 28 is a concept present in the
descriptive accounts of ﬁndings, in the primary data
reported, and implicitly as the goal that patients and
spouses strive towards during the transitions that they
undergo post-DBS. We propose that normality has a dual
meaning. First, normality as a state can be opposed to the
diseased state and the impacts of that diseased state, that
is, it represents a prediseased life. Patients seek to main-
tain this using medication in the early stages of PD, via
control of the disease and its impacts. However, as PD
progresses, normality is also a descriptor for a state
whereby patients are able to maintain an adjusted life
which accommodates the disease. Normality is condi-
tional on perceived control over the disease and its man-
agement. In other words, loss of control, an inability to
predict and manage the impacts of the disease, means
that patients and spouses can no longer maintain any
sense of normality:
More than half of the couples experienced that nothing
was ‘normal’ for a long period of adjustment [to stimula-
tion]. This put a strain on both parties and on their rela-
tionship. (Author interpretation27)
Loss and loss of control
Progressive PD results in loss. Impacts include impaired
physical function and ability to do things; unpredictabil-
ity of everyday life and the associated inability to plan
ahead (loss of freedom); weakened social ties, friend-
ships and relationships; loss of time as medication
Table 2 Presence of core cross-cutting themes interpreted within the chronology for each study
Reference Loss Loss of control Hope Normality Transitions
Haahr et al24* Yes (in Haahr et al26) Yes Yes Yes† Yes
Haahr et al27 Yes Yes† Yes Yes Yes
Haahr et al26 Yes Yes Yes Not
covered
NA‡
Gisquet19 Yes Yes—core concept in
paper
Yes Yes† Yes
Ahlberg et al25 Yes (but postsurgery loss associated
with voice)
Yes† Yes Yes† Yes
Hariz and
Hamberg28
Not covered Yes Yes Yes† Yes
Agid et al11 Yes Not covered Not
covered
Yes† Yes
*Index paper from which mapping of the comparisons across the cohort of papers was undertaken.
†Findings translated into those of other papers.
‡Paper focuses on predeep brain stimulation perspectives.
NA, not available.
Figure 2 Chronology of patient’s and spouses’ experiences of Parkinson’s disease and deep brain stimulation.
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regimes are predominant; and loss of elements of rela-
tionships with spouses, for example, intimacy, joint
activities, independence and time for oneself, compan-
ionship.11 19 24–27
There has been loss of many things. Loss of the person
you married, loss of abilities, loss of strength…I have
experienced social isolation. Having to ﬁnd a new iden-
tity, a new social life, a new way of living life…we have
talked about what possibilities we have. How can we com-
pensate for what we have lost? (Spouse27)
Late stage PD is characterised by perceived loss of
control over the disease and impacts of disease. There is
an increased lack of predictability. The resultant fear of
negative consequences of this loss of control (eg, going off
in public) places further constraints on patients and
spouses. The condition (control) that allows mainten-
ance of some sense of normality is removed from their
grasp, so that even ‘a new identity, social life and way of
living’, as described above,27 is compromised.
The ability to attain some perceived control post-DBS
may be crucial to transitions that must be undertaken in
order to allow patients and spouses to attain some sense
of a (new) normality.
Transitions
Following the initial postsurgery euphoria,11 19 25–28 for
many, there is a need to undergo wide ranging transi-
tions11 19 24 25 27 28 in order to adjust to a post-DBS life.
Some patients report this as a decline, although it is
unclear whether this is a genuine physical decline or a
manifestation of the realisation that DBS necessitates
complex transitions. These transitions are physical and
bodily, functional and activity-related, social and relation-
ships, and psychological.
Physical and bodily transitions include the need for
adjustments in stimulation parameters in order to estab-
lish ‘optimal’ settings in conjunction with medication,
with testing and retesting of these. For some, this is a
prolonged process with a need for multiple hospital
visits and adjustments:
After the setting, it feels good for a day or two, and after
that it starts to pull in my face, with pain in my chin.
(Patient28)
In some cases, this necessitates trade-offs, for example,
between settings which optimise motor function or
speech:
I have trouble speaking. I have to learn to live with that,
because if the stimulation is adjusted to improve my
speech, then I have trouble walking. (Patient24)
This is also a time of testing the new boundaries and
limits of physical and functional ability and engagement
in activities.
Social transitions include redeﬁnition of the boundar-
ies of social activities and friendships. For some, relation-
ships with spouses must also change. ‘Normal’
relationships are likely to have been lost during disease
progression, as spouses take on and agree new roles
within a relationship—carer as well as partner. Following
surgery, couples may need to renegotiate roles. This is
clearly a potential source of strain within relationships
when consensus about new roles is difﬁcult to attain:
…[we] were [the] perfect couple, since the operation he
wants to live like a young man: going out, meeting new
people…it’s unbearable! I prefer him as he was before,
always nice and quiet. (Spouse11)
There are examples11 19 24 27 of patients wanting to
re-establish former roles and feeling that spouses are
overprotective, as well as conﬂicting expectations.
Spouses who see substantial improvements in motor
function are disappointed when partners do not change
behaviour accordingly. Patients report the persistence of
symptoms and struggle with such physical transitions:
My wife cannot tell when I am feeling bad, and then she
thinks I am lazy. She starts fussing, telling me to get my
act together…and I try, but when I am in pain or in
some other way cannot function, then there is nothing to
do about it. (Patient24)
Loss of initiative11 19 24 27 is noted in several of the
papers. Despite improvement in motor disability, often
this is not reﬂected in patients’ behaviour, for example,
they do not want to pursue new activities, or lack interest
in work where previously it was a focus;
Before, I was absolutely determined to carry on working.
For me, it was a way of ﬁghting the illness. I wanted to
show that I was still capable. After the surgery, I realised
that there were more important things, like having time,
or seeing my grandchildren grow up. (Patient19)
Spouses are reported as drivers of change, encour-
aging patients to test the boundaries of their abilities,
although as above, this can be a source of tension where
change is not apparent:27
I am very alert that he doesn’t get too comfortable…such
as he asks me to get him things and I tell him to get up
and get them himself. (Spouse27)
Patients must cope psychologically with these transi-
tions. There may be a hangover from the pre-DBS
period that was characterised by unpredictability and loss
of control, despite postsurgery improvements in motor
function. The fear of the consequences of unpredictabil-
ity may remain:
Even though I know my motor state is perfectly normal, I
just can’t get rid of the thoughts I used to have, when I
was ill. I still have the same reﬂexes to initiate walking
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and the rituals before taking the medicine. I always
refuse invitations to go out because I imagine I’ll have
freezing attacks and walking problems, even though it’s
no longer the case. My body is cured but my mind is still
sick. (Patient11)
This also appears to be a time when patients and
spouses have not regained control over the management
of the disease which is largely in the hands of the health-
care professionals who guide the adjustment of stimula-
tion parameters.
Hope may be a key psychological contingency which
inﬂuences the experience of these transitions.
Hopes
Although only labelled explicitly in one of the papers as
a subtheme,24 hopes for the outcome and impact of DBS
are implicit in much of these data. In the face of a sig-
niﬁcant history of loss and loss of control in late stage PD,
hopes to counteract the progressive impact and decline
associated with the disease are strong:
I think it will be easier…that is the impression I get…I
think so…some talk of it as getting a new life [laughing]
…I don’t need a new life, but an easier life wouldn’t be
so bad. (Patient26)
The evidence suggests that patients do not necessarily
know what to expect:
Nobody knows what happens after the operation, right?
It is easier to relate to taking tablets and then you can go
on again, but we don’t know after the operation…It is
like a new day 1. Like when I got ill—then life starts from
there…so this will happen again on the 19th[date of
surgery] then life starts all over again…[laughs].
(Patient26)
However, this may not reﬂect a lack of information or
understanding that sets ‘expectations’ too highly, as
much as hopes to regain what has been lost:
I have experienced an overall improvement. I can walk, I
can get in and out of bed, and I don’t use my wheelchair
anymore…that I had expected more is my fault, looking
back, the expectations I had were unrealistic. There were
no grounds for the improvements I had hoped for. But I
had read interviews with patients who had had the oper-
ation, and they were all positive. They said nothing of the
other side of the coin. And I read it as this was a miracle
cure…and it is…but the miracles do stick to the ground.
(Patient24)
There is also evidence of patients rejecting the cau-
tious counselling of expectations from healthcare profes-
sionals, in favour of post-DBS accounts that align with
hopes for particular outcomes:
They [the doctors] say not to expect too much, but I
don’t know. I think it will be good. I know somebody who
has had it done and they are very satisﬁed, so why
shouldn’t I be? (Patient26)
Patients may wish for further improvements during
transitions via reﬁnements in stimulation parameters:
Can’t you move the electrodes a bit, a millimetre or less?
Or at least increase the stimulation? I am sure it is pos-
sible to improve the parameters so that I feel better.
(Patient11)
This may be inter-related with pre-DBS hopes for the
procedure which are not necessarily realised fully for
patients and spouses. In turn, there may be a need for
psychological resolution and realisation that this is ‘as
good as it gets’ in order to accommodate the post-DBS
state. Haahr et al24 term this ‘reconciliation’.
DISCUSSION
We have synthesised seven studies.11 19 24–28 At present,
this is a relatively small body of work, although it does
represent in-depth qualitative investigation with patients
from a range of settings and at a range of time points
after DBS. Three of the papers stem from the same
Danish data set.24 26 27 Additionally, one of these
papers24 was key in the early stages of the synthesis as it
provided a conceptually rich account of the experience
of DBS that aided the translation of studies into one
another. Naturally, this requires reﬂection as to whether
this one data set has skewed our synthesis and ultimately
the interpretation and line of argument presented here.
We do not believe this to be the case as the core con-
cepts identiﬁed occur across the majority of the papers,
thereby strengthening the case for the interpretation
given. However, we acknowledge that there is a need for
further primary research in different and varied settings
and patient populations, to improve our knowledge in
this area. In addition, there is a need to further examine
spouses’ experiences and insights. Only one of the
papers we identiﬁed explored this in detail,27 which is a
clear deﬁcit of knowledge in this area. We included this
study as we felt that it was able to shed valuable light on
the experience of DBS, and also because other papers
reported the impacts of DBS on aspects of relationships
from a patient perspective. Two papers11 19 were rated
low quality based on methodological reporting but were
conceptually rich. We included these in the synthesis as
conceptual richness is recognised as a key indicator of
the utility of individual studies for qualitative synthesis,
and for metaethnography in particular.20
We suggest that normality is a core concept which facili-
tates understanding of the experiences of DBS. Normality
is a complex concept that has been used to understand
the patient experience of other diseases. For example,
Sanderson et al30 have used it as an explanatory tool for
patients’ experience of rheumatoid arthritis (RA), and it
has also been used to understand patient perspectives
on motor neuron disease (MND).31 Here, normality has
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a dual meaning and describes both a prediseased state
and life, but also a state whereby patients and spouses
are able to adopt an adjusted life accommodating the
disease and its impacts. The latter has also been
described as a form of ‘normalisation’ of disease in
studies that focus on adaptation to chronic illness,
whereby patients come to see and treat the illness as
‘normal’,32 33 developing iterative strategies in the
actions that they take in living with the illness. We
propose that a sense of control is a condition for this
form of normality in PD. Patients have lost this control in
late stage PD and do not regain it immediately following
surgery due to the complex multifaceted transitions that
they face while adjusting to the post-DBS disease state.
Hopes to regain what has been lost as a result of the
illness and for further improvements via adjustment in
stimulation may be key psychological contingencies for
successfully negotiating these transitions, and attaining
what we have called a ‘new normality’. This is similar to
what has been termed ‘resetting normality’ in RA and a
‘dynamic normality’ in MND.30 31
This way of conceptualising post-DBS patient experi-
ence provides a potentially explanatory framework for
some of the observations in the trial and observational
quantitative evidence. While negative assessments
(eg, QoL; subjective ratings) by patients and spouses
post-DBS3 4 8 9 may well have a biomedical component, it
is crucial to acknowledge the complex transitions for
patients and those around them. Patients are clearly not
inexplicably struggling in the face of a seemingly miracu-
lous recovery of motor function. Symptoms persist
post-DBS during the transitions that are undertaken.
Hopes may be key, and despite careful counselling and
information giving to patients, they may retain hopes for
the procedure that are unattainable. This has been
observed in the use of DBS for treatment-resistant depres-
sion34 and previously in DBS for PD. For example,
Montel and Bungener (ref. 35, p. 109) comment:
…our clinical experience has led us to the conclusion
that for many patients with PD who are to be treated with
stimulation, their expectations are too unrealistic, which
accounts for their disappointment 12 months later. Most of
them consider the stimulation to be a “magic” process that
is going to free them entirely from their physical impair-
ment. When they are confronted with reality (namely, that
they can be improved but not totally cured by stimulation),
they are very disappointed. In fact, the problem is not the
presentation of information about DBS by neurologists but
rather the way the candidates interpret it. Most often, can-
didates “hear” what they want to hear, that is, that after the
stimulation, they will return to life as it was before PD.
This may be a consequence of the loss and loss of
control experienced prior to DBS, such that hopes to
regain a predisease normality may outweigh ‘reasoned’
expectations for improvements.
Stimulation adjustment can be long and difﬁcult. The
prospect that such adjustment can realise further
improvements that are not yet apparent may prolong hopes
for outcomes (eg, normality) that cannot be realised, pre-
venting patients from accommodating DBS as quickly as
they may otherwise do. Patients may also fear testing the
boundaries of their physical abilities, which is perhaps a
psychological hangover from the impacts of previous
motor function. This may not be immediately apparent to
healthcare professionals, or even spouses. The latter are
likely to be a key catalyst in change and support, but at the
same time, there is a need for patients and spouses to
adjust to new roles within their relationships.
The ﬁndings from meta-analysis, individual trial data
and observational studies are reﬂected in this qualitative
research. Negative social support, emotional well-being
and communication outcomes seem well explained by
the qualitative data. Measurement of outcomes in the
short term (3 or 6 months) is likely to coincide with the
transitions described, impacting on patient-reported out-
comes, and implying that longer follow-up is required.
Also, if key holistic assessments of the impacts of DBS
are to be made, then outcome measures should ideally
capture concepts such as normality and control. The pre-
dominant primary outcome measure used in DBS trials,
PDQ-39, measures items in eight domains (mobility,
activities of daily living, emotional well-being, stigma,
social support, cognitions, communication and bodily
discomfort). Each of these domains can be interpreted
within the qualitative evidence via patients’ and spouses’
accounts of the impacts of DBS. This provides further
validation that PDQ-39 does measure items of import-
ance to patients and spouses, and within the context of
DBS. While outcome measures such as PDQ-39 have
been developed using primary qualitative data (in-depth
interviews),36 our synthesis suggests that measures which
capture the impact of treatments on control and normality
may also prove useful.
At present, the body of qualitative evidence under-
pinning our knowledge of the experience and impact
of DBS is small. Additional longitudinal investigation of
the transitions described here is needed to further
understand and facilitate these transitions. This should
use mixed-methods research techniques featuring well-
designed qualitative investigation with patients and
spouses, alongside quantitative data. Key areas for
research are likely to include a focus on pre-DBS and
post-DBS information giving and support; the experi-
ence of the stimulation adjustment process post
surgery; the nature and role of social support during
transitional periods including the impact on relation-
ships; and the role of professional support throughout
this period. Our ﬁndings also suggest the need for
further reﬂection on the use of DBS earlier in PD pro-
gression, although this practice is currently being
debated within the PD/DBS community.37 38 Using
DBS at an earlier stage, when patients are able to main-
tain some control and normality, may be a similarly dis-
ruptive experience with need for equivalent transitions
and loss of control during these.
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CONCLUSIONS
Our synthesis identiﬁes ﬁve core concepts: normality, loss,
loss of control, transitions and hopes which facilitate our
understanding of the experience of DBS for patients and
their spouses. There is a clear need for further research
to explore the exact nature of the transitions described
here and how best patients and their spouses can be sup-
ported by healthcare professionals and others, before,
during and after DBS for PD. In assessing the impacts of
DBS, and other treatments in late stage PD, we should
consider how to capture the impacts on holistic concepts
such as control and normality. Studies that examine the out-
comes of DBS require longer term follow-up.
Contributors JM and LLJ conceived the idea for the research (in conjunction
with CR and CJ), conducted the initial review and data analysis, and wrote the
first draft of the manuscript. SB designed and conducted the literature
searches. RG advised on review design, conduct and presentation. All authors
contributed to data interpretation and subsequent revisions to the manuscript.
All authors have read and agreed the final version of the manuscript.
Funding This work was part funded by the Medical Research Council Midland
Hub for Trials Methodology Research (Grant Number: G0800808). RG is
partially supported by the National Institute for Health Research (NIHR)
Collaboration for Leadership in Applied Health Research and Care (CLAHRC)
for the South West Peninsula (PenCLAHRC).
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
REFERENCES
1. Schuepbach WM RJ, Knudsen K, Volkmann J, et al. EARLYSTIM
Study Group. Neurostimulation for Parkinson’s disease with early
motor complications. N Engl J Med 2013;14:610–22.
2. Perestelo-Pérez L, Rivero-Santana A, Pérez-Ramos J, et al. Deep
brain stimulation in Parkinson’s disease: meta-analysis of
randomized controlled trials. J Neurol 2014;261:2051–60.
3. Daniels C, Krack P, Volkmann J, et al. Is improvement in the quality
of life after subthalamic nucleus stimulation in Parkinson’s disease
predictable? Mov Disord 2011;26:2516–21.
4. Soulas T, Sultan S, Gurruchaga JM, et al. Depression and coping as
predictors of change after deep brain stimulation in Parkinson’s
disease. World Neurosurg 2011;75:525–32.
5. Diamond A, Jankovic J. The effect of deep brain stimulation on
quality of life in movement disorders. J Neurol Neurosurg Psychiatr
2005;76:1188–93.
6. Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality
of life are significantly improved by bilateral subthalamic stimulation
in Parkinson’s disease. J Neurol 2005;252:583–8.
7. Smeding HM, Speelman JD, Huizenga HM, et al. Predictors of
cognitive and psychosocial outcome after STN DBS in
Parkinson’s disease. J Neurol Neurosurg Psychiatr 2011;82:
754–60.
8. Lewis CJ, Maier F, Horstkötter N, et al. The impact of subthalamic
deep brain stimulation on caregivers of Parkinson’s disease patients:
an exploratory study. J Neurol 2015;262:337–45.
9. Maier F, Lewis CJ, Horstkoetter N, et al. Patients’ expectations of
deep brain stimulation, and subjective perceived outcome related to
clinical measures in Parkinson’s disease: a mixed-method approach.
J Neurol Neurosurg Psychiatr 2013;84:1273–81.
10. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide
outcomes following subthalamic stimulation for Parkinson’s disease.
Brain 2008;131:2720–8.
11. Agid Y, Schüpbach M, Gargiulo M, et al. Neurosurgery in
Parkinson’s disease: the doctor is happy, the patient less so?
J Neural Transm Suppl 2006;70:409–14.
12. O’Cathain A, Thomas KJ, Drabble SJ, et al. Maximising the value of
combining qualitative research and randomised controlled trials in
health research: the QUAlitative Research in Trials (QUART) study
—a mixed methods study. Health Technol Assess 2014;18:1–197.
13. Barnett-Page E, Thomas J. Methods for the synthesis of qualitative
research: a critical review. BMC Med Res Methodol 2009;9:59.
14. Evans D. Database searches for qualitative research. J Med Libr
Assoc 2002;90:290–3.
15. Shaw RL, Booth A, Sutton AJ, et al. Finding qualitative research:
an evaluation of search strategies. BMC Med Res Methodol 2004;4:5.
16. Barbour R. Checklists for improving rigour in qualitative research:
a case of the tail wagging the dog? BMJ 2001;5:1115–17.
17. Garside R. Should we appraise the quality of qualitative research
reports for systematic reviews, and if so, how? Eur J Soc Sci Res
2014;27:67–79.
18. Critical Appraisal Skills Programme (CASP). Qualitative Research
Checklist. Secondary Qualitative Research Checklist http://media.
wix.com/ugd/dded87_29c5b002d99342f788c6ac670e49f274.pdf
(accessed 31 May 2013).
19. Gisquet E. Cerebral implants and Parkinson’s disease: a unique
form of biographical disruption? Soc Sci Med 2008;67:1847–51.
20. Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative
studies. Newbury Park, CA, USA: Sage, 1988.
21. Britten N, Campbell R, Pope C, et al. Using meta ethnography to
synthesise qualitative research: a worked example. J Health Serv
Res Policy 2002;7:209–15.
22. Campbell R, Pound P, Morgan M, et al. Evaluating
meta-ethnography: systematic analysis and synthesis of qualitative
research. Health Technol Assess 2011;15:1–164.
23. Tong A, Flemming K, McInnes E, et al. Enhancing transparency in
reporting the synthesis of qualitative research: ENTREQ. BMC Med
Res Methodol 2012;12:181.
24. Haahr A, Kirkevold M, Hall EO, et al. From miracle to reconciliation:
a hermeneutic phenomenological study exploring the experience of
living with Parkinson’s disease following deep brain stimulation. Int J
Nurs Stud 2010;47:1228–36.
25. Ahlberg E, Laakso K, Hartelius L. Perceived changes in
communication as an effect of STN surgery in Parkinson’s disease:
a qualitative interview study. Parkinsons Dis 2011;2011:540158.
26. Haahr A, Kirkevold M, Hall EO, et al. Living with advanced
Parkinson’s disease: a constant struggle with unpredictability.
J Adv Nurs 2011;67:408–17.
27. Haahr A, Kirkevold M, Hall EO, et al. ‘Being in it together’: living with
a partner receiving deep brain stimulation for advanced Parkinson’s
disease—a hermeneutic phenomenological study. J Adv Nurs
2013;69:338–47.
28. Hariz GM, Hamberg K. Perceptions of living with a device-based
treatment: an account of patients treated with deep brain stimulation
for Parkinson’s disease. Neuromodulation 2014;17:272–8.
29. Soundy A, Stubbs B, Roskell C. The experience of Parkinson’s
disease: a systematic review and meta-ethnography. SCI World J
2014;2014:613592.
30. Sanderson T, Calnan M, Morris M, et al. Shifting normalities:
interactions of changing conceptions of a normal life and the
normalisation of symptoms in rheumatoid arthritis. Sociol Health Illn
2011;33:618–33.
31. Brown J, Addington-Hall J. How people with motor neurone disease
talk about living with their illness: a narrative study. J Adv Nurs
2008;62:200–8.
32. Bury M. The sociology of chronic illness: a review of research and
prospects. Sociol Health Illn 1991;13:451–68.
33. Bury M. Illness narratives: fact or fiction? Sociol Health Illn
2001;23:263–85.
34. Johansson V, Garwicz M, Kanje M, et al. Beyond blind optimism and
unfounded fears: deep brain stimulation for treatment resistant
depression. Neuroethics 2013;6:457–71.
35. Montel SR, Bungener C. Coping and quality of life of patients with
Parkinson disease who have undergone deep brain stimulation of
the subthalamic nucleus. Surg Neurol 2009;72:105–10.
36. Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson’s Disease
Questionnaire (PDQ-39): development and validation of a Parkinson’s
disease summary index score. Age Ageing 1997;26:353–7.
37. Charles D, Konrad PE, Neimat JS, et al. Subthalamic nucleus deep
brain stimulation in early stage Parkinson’s disease. Parkinsonism
Relat Disord 2014;20:731–7.
38. Hariz M. There is no credible rational for deep brain stimulation in
very early Parkinson’s disease! (Comment). Parkinsonism Relat
Disord 2015;21:345–6.
10 Mathers J, et al. BMJ Open 2016;6:e011525. doi:10.1136/bmjopen-2016-011525
Open Access
copyright.
 o
n
 13 August 2019 at University of Nottingham
. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-011525 on 23 June 2016. Downloaded from 
